EOLS
EvolusBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
EOLS vs peer average
66/100
EOLS vs. peer average (B vs. C)
Grade spread
A 2 · B 2 · C 1 · D 4 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ABBV is the first available peer comparator.
AbbVie is a direct operating competitor in aesthetics through Botox and a broader injectables portfolio, making it more relevant for competitive pressure, pricing, bundling, and customer-contract risk than the packet's same-sector small-cap biotech peers. Its much larger scale means it should not be used as a clean valuation comp for Evolus.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
EOLS
Evolus
ABBV
AbbVie
Grade
B
B
Momentum
25
72
Value
41
61
Sentiment
100
34
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ABBV
EOLS / ABBV
Grade Position
In line
EOLS vs. peer average (B vs. C)
66/100
Momentum
25
ABBVValue
41
ABBVSentiment
100
EOLSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs EOLS
ABBV is the first peer returned for this comparison set.